Design of therapeutic proteins with enhanced stability
Therapeutic proteins such as antibodies constitute the most rapidly growing class of pharmaceuticals for use in diverse clinical settings including cancer, chronic inflammatory diseases, kidney transplantation, cardiovascular medicine, and infectious diseases. Unfortunately, they tend to aggregate w...
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
United States National Academy of Sciences
2010
|
| Online Access: | http://hdl.handle.net/1721.1/52552 https://orcid.org/0000-0003-1417-9470 |